• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿莫地喹诱导的粒细胞缺乏症:抗疟药对骨髓集落生长的抑制作用。

Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.

作者信息

Rhodes E G, Ball J, Franklin I M

出版信息

Br Med J (Clin Res Ed). 1986 Mar 15;292(6522):717-8. doi: 10.1136/bmj.292.6522.717.

DOI:10.1136/bmj.292.6522.717
PMID:3082409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1339776/
Abstract

Bone marrow was cultured in vitro for colonies of granulocytes and macrophages five months after a patient had recovered from amodiaquine induced agranulocytosis. The addition of amodiaquine, chloroquine, and sulfadoxine to the culture was followed by a dose dependent inhibition of colony growth in the patient's marrow but not in normal control bone marrow. Colony growth was, however, unaffected by proguanil, pyrimethamine, and quinine. These findings show that in vitro marrow culture may have important predictive value in some cases of drug induced agranulocytosis.

摘要

一名患者从阿莫地喹诱发的粒细胞缺乏症康复五个月后,其骨髓在体外培养以形成粒细胞和巨噬细胞集落。在培养物中添加阿莫地喹、氯喹和周效磺胺后,患者骨髓中的集落生长受到剂量依赖性抑制,但正常对照骨髓中未受影响。然而,氯胍、乙胺嘧啶和奎宁对集落生长没有影响。这些发现表明,体外骨髓培养在某些药物诱发的粒细胞缺乏症病例中可能具有重要的预测价值。

相似文献

1
Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.阿莫地喹诱导的粒细胞缺乏症:抗疟药对骨髓集落生长的抑制作用。
Br Med J (Clin Res Ed). 1986 Mar 15;292(6522):717-8. doi: 10.1136/bmj.292.6522.717.
2
Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cells.阿莫地喹诱发的粒细胞缺乏症:1例报告及粒细胞-巨噬细胞祖细胞的体外研究
Acta Haematol. 1989;82(1):40-2. doi: 10.1159/000205276.
3
Neutropenia associated with dual antimalarial chemoprophylaxis--use of bone-marrow culture as an aid in further drug management.与双重抗疟化学预防相关的中性粒细胞减少症——利用骨髓培养辅助进一步的药物管理。
J Infect. 1987 Sep;15(2):147-52. doi: 10.1016/s0163-4453(87)93130-6.
4
Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro.阿莫地喹诱导的粒细胞缺乏症:阿莫地喹在体外骨髓培养中的毒性作用。
Br Med J. 1973 Feb 24;1(5851):458-60. doi: 10.1136/bmj.1.5851.458.
5
Amodiaquine-induced agranulocytosis: drug inhibition of myeloid colonies in the presence of patient's serum.阿莫地喹诱导的粒细胞缺乏症:在患者血清存在的情况下药物对髓系集落的抑制作用。
Isr J Med Sci. 1985 Apr;21(4):331-4.
6
[Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].[氯喹和磺胺多辛-乙胺嘧啶在阿比让北部(科特迪瓦)疗效的局限性:体内和体外联合研究]
Sante. 2004 Oct-Dec;14(4):205-9.
7
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.奥里萨邦孙德尔加尔地区部落人群中恶性疟原虫对氯喹、阿莫地喹、奎宁、甲氟喹和磺胺多辛/乙胺嘧啶的敏感性状况
Indian J Malariol. 1992 Dec;29(4):211-8.
8
The in vitro effect of amodiaquine on bone marrow granulocyte-macrophage progenitor cells from normal subjects.阿莫地喹对正常受试者骨髓粒-巨噬细胞祖细胞的体外作用。
Fundam Clin Pharmacol. 1992;6(1):1-4. doi: 10.1111/j.1472-8206.1992.tb00086.x.
9
In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.乌干达西部恶性疟原虫对氯喹、氨酚喹及磺胺多辛-乙胺嘧啶的体内敏感性
Trop Geogr Med. 1994;46(6):364-5.
10
Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine.在尼日利亚一个对氯喹和磺胺多辛/乙胺嘧啶具有高度耐药性的地区,阿莫地喹治疗非复杂性恶性疟的疗效。
Parasitol Res. 2005 Jun;96(3):162-5. doi: 10.1007/s00436-005-1325-7. Epub 2005 Apr 28.

引用本文的文献

1
Hematoxicity of amodiaquine in sprague-dawley rats.阿莫地喹对斯普拉格-道利大鼠的血液毒性
Toxicol Int. 2012 May;19(2):112-4. doi: 10.4103/0971-6580.97197.
2
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.阿莫地喹-青蒿琥酯与蒿甲醚-本芴醇治疗加纳儿童非复杂性疟疾的疗效与安全性比较:一项为期一年随访的随机对照试验
Malar J. 2008 Jul 11;7:127. doi: 10.1186/1475-2875-7-127.
3
Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.基于周效磺胺-乙胺嘧啶的联合用药治疗疟疾:在马拉维进行的一项比较疗效、安全性及耐药性选择的随机双盲试验
PLoS One. 2008 Feb 13;3(2):e1578. doi: 10.1371/journal.pone.0001578.
4
Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.药物不良反应的免疫学原理:药物治疗引发的免疫反应的启动与传播。
Drug Saf. 2000 Dec;23(6):483-507. doi: 10.2165/00002018-200023060-00002.
5
Effect of dose size on amodiaquine pharmacokinetics after oral administration.
Eur J Clin Pharmacol. 1987;33(3):331-3. doi: 10.1007/BF00637573.
6
Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria.单次口服阿莫地喹后单去乙基阿莫地喹的处置及三种预防恶性疟原虫疟疾的方案
Eur J Clin Pharmacol. 1987;33(4):409-14. doi: 10.1007/BF00637639.
7
Development of recommendations for the protection of short-stay travellers to malaria endemic areas: Memorandum from two WHO Meetings.针对前往疟疾流行地区的短期旅行者的保护建议制定:世卫组织两次会议的备忘录
Bull World Health Organ. 1988;66(2):177-96.
8
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.阿莫地喹、氯喹和甲氟喹对人多形核中性粒细胞体外功能的影响。
Antimicrob Agents Chemother. 1988 Aug;32(8):1124-30. doi: 10.1128/AAC.32.8.1124.
9
Antimalarial agents: specific chemoprophylaxis regimens.抗疟药:特定的化学预防方案。
Antimicrob Agents Chemother. 1988 Jul;32(7):953-6. doi: 10.1128/AAC.32.7.953.
10
The disposition of amodiaquine in Zambians and Nigerians with malaria.阿莫地喹在赞比亚和尼日利亚疟疾患者中的处置情况。
Br J Clin Pharmacol. 1990 Jun;29(6):695-701. doi: 10.1111/j.1365-2125.1990.tb03690.x.

本文引用的文献

1
Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro.阿莫地喹诱导的粒细胞缺乏症:阿莫地喹在体外骨髓培养中的毒性作用。
Br Med J. 1973 Feb 24;1(5851):458-60. doi: 10.1136/bmj.1.5851.458.